Paul Isaac - Arbiter Partners Capital Management 13F Activity & Position Changes (Q3 2024)

As of Sep 30, 2024, the Arbiter Partners Capital Management portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Nov 13, 2024. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q3 2024, the filing reported:

New Buys - Inhibrx Biosciences, Inc.

Increases - GRAIL, Inc., Stereotaxis, Inc.

Reductions - Lennar Corporation, Liberty Latin America Ltd, Logan Ridge Finance Corporation, Sonida Senior Living, Inc.

Complete Exits - Great Elm Group, Inc., Labcorp Holdings Inc., Lincoln National Corporation

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q3 2024	GEG Great Elm Group, Inc.	Great Elm Group, Inc.	Sell - Position Exit	-255,728	-100.0%	$0.00	-
Q3 2024	GRAL GRAIL, Inc.	GRAIL, Inc.	Buy	+129,108	+92.2%	$3.70M	269,108
Q3 2024	INBX Inhibrx Biosciences, Inc.	Inhibrx Biosciences, Inc.	Buy - Position Entry	+28,095	-	$439.97K	28,095
Q3 2024	LEN-B Lennar Corporation	Lennar Corporation	Sell	-798	-10.4%	$1.19M	6,889
Q3 2024	LH Labcorp Holdings Inc.	Labcorp Holdings Inc.	Sell - Position Exit	-8,100	-100.0%	$0.00	-
Q3 2024	LILAK Liberty Latin America Ltd	Liberty Latin America Ltd	Sell	-10,000	-2.7%	$3.41M	359,048
Q3 2024	LNC Lincoln National Corporation	Lincoln National Corporation	Sell - Position Exit	-11,000	-100.0%	$0.00	-
Q3 2024	LRFC Logan Ridge Finance Corporation	Logan Ridge Finance Corporation	Sell	-842	-1.4%	$1.50M	60,271
Q3 2024	SNDA Sonida Senior Living, Inc.	Sonida Senior Living, Inc.	Sell	-42,646	-11.7%	$8.54M	320,983
Q3 2024	STXS Stereotaxis, Inc.	Stereotaxis, Inc.	Buy	+9,349	+0.3%	$5.69M	2,791,068